Pfizer vs AstraZeneca: Revenue Comparison
Pfizer (PFE) and AstraZeneca (AZN) are peers in GLP-1. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $15.3B for AstraZeneca. AstraZeneca leads on revenue.
Pfizer's gross margin is 67.3% versus 82.5% for AstraZeneca. Pfizer's net margin is 18.6% versus 20.1% for AstraZeneca.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, AstraZeneca 15.288.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, AstraZeneca.| Metric | Pfizer | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $15.29B |
| Cost of Revenue | $4.73B | $2.68B |
| Gross Profit | $9.72B | $12.61B |
| Operating Income | $4.03B | $4.25B |
| Net Income | $2.69B | $3.08B |
| R&D Expense | $2.63B | $3.49B |
| Earnings Per Share | $0.47 | $3.94 |
| Gross Margin | 67.3% | 82.5% |
| Operating Margin | 27.9% | 27.8% |
| Net Profit Margin | 18.6% | 20.1% |
| Free Cash Flow | $2.18B | $1.82B |
| Cumulative Free Cash Flow | $356.40B | $119.09B |
| Operating Cash Flow | $2.62B | $3.36B |
| Cash & Equivalents | $1.70B | $7.56B |